J, M., HFE, G., HT, C., CN, H., S, V., AM, V., . . . AF, L. (2023). Biological drivers of clinical phenotype in myelofibrosis. Leukemia, 37(2), 255. https://doi.org/10.1038/s41375-022-01767-y
Chicago Style (17th ed.) CitationJ, Mascarenhas, et al. "Biological Drivers of Clinical Phenotype in Myelofibrosis." Leukemia 37, no. 2 (2023): 255. https://doi.org/10.1038/s41375-022-01767-y.
MLA (9th ed.) CitationJ, Mascarenhas, et al. "Biological Drivers of Clinical Phenotype in Myelofibrosis." Leukemia, vol. 37, no. 2, 2023, p. 255, https://doi.org/10.1038/s41375-022-01767-y.
Warning: These citations may not always be 100% accurate.